Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Therapeutic Advances in Infectious Disease
|
May 17, 2021
Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms
Kenneth P Klinker, Levita K Hidayat, C Andrew DeRyke, et al.
The Journal of Antibiotics
|
August 1, 2024
Antibacterial and mechanism of action studies of boxazomycin A
Sheo B Singh, James Occi, John Ondeyka, et al.
Antimicrobial Agents and Chemotherapy
|
December 15, 2020
Molecular Characterization of Baseline <i>Enterobacterales</i> and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial
Mariana Castanheira, Matthew G Johnson, Brian Yu, et al.
Emerging Infectious Diseases
|
May 19, 2018
Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008-2014
Gisele Peirano, Yasufumi Matsumura, Mark D Adams, et al.
Antibiotics (Basel, Switzerland)
|
May 28, 2022
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States
Kenneth P Klinker, Levita K Hidayat, Eric Wenzler, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2018
Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar
Saad J Taj-Aldeen, Husam Salah, Winder B Perez, et al.
International Journal of Antimicrobial Agents
|
January 12, 2021
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)
Matthew G Johnson, Christopher Bruno, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
<i>In Vivo</i> Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection Models
Mary Ann Powles, Andrew Galgoci, Andrew Misura, et al.
Infectious Diseases and Therapy
|
June 12, 2016
In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study
Douglas J Biedenbach, Robert E Badal, Ming-Yi Huang, et al.
Infectious Diseases and Therapy
|
July 18, 2016
Erratum to: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study
Douglas J Biedenbach, Robert E Badal, Ming-Yi Huang, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Therapeutic Advances in Infectious Disease
|
May 17, 2021
Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms
Kenneth P Klinker, Levita K Hidayat, C Andrew DeRyke, et al.
The Journal of Antibiotics
|
August 1, 2024
Antibacterial and mechanism of action studies of boxazomycin A
Sheo B Singh, James Occi, John Ondeyka, et al.
Antimicrobial Agents and Chemotherapy
|
December 15, 2020
Molecular Characterization of Baseline <i>Enterobacterales</i> and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial
Mariana Castanheira, Matthew G Johnson, Brian Yu, et al.
Emerging Infectious Diseases
|
May 19, 2018
Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008-2014
Gisele Peirano, Yasufumi Matsumura, Mark D Adams, et al.
Antibiotics (Basel, Switzerland)
|
May 28, 2022
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States
Kenneth P Klinker, Levita K Hidayat, Eric Wenzler, et al.
Antimicrobial Agents and Chemotherapy
|
June 27, 2018
Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar
Saad J Taj-Aldeen, Husam Salah, Winder B Perez, et al.
International Journal of Antimicrobial Agents
|
January 12, 2021
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)
Matthew G Johnson, Christopher Bruno, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
<i>In Vivo</i> Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection Models
Mary Ann Powles, Andrew Galgoci, Andrew Misura, et al.
Infectious Diseases and Therapy
|
June 12, 2016
In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study
Douglas J Biedenbach, Robert E Badal, Ming-Yi Huang, et al.
Infectious Diseases and Therapy
|
July 18, 2016
Erratum to: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study
Douglas J Biedenbach, Robert E Badal, Ming-Yi Huang, et al.
Page
of 5